Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram

Figure 5 Percentage of chronic liver disease etiology combined with metabolic dysfunction-associated steatotic liver disease and no metabolic dysfunction-associated steatotic liver disease. A: Other liver diseases; B: Pure metabolic dysfunction-associated steatotic liver disease; C: Hepatitis B virus; D: Autoimmune hepatitis; E: Drug-induced liver injury; F: Hepatitis C virus; G: Primary biliary cholangitis; H: Alcoholic liver disease. ^aP < 0.05; ^bP < 0.01. OLD: Other liver diseases; MASLD: Metabolic dysfunction-associated steatotic liver disease; HBV: Hepatitis B virus; AIH: Autoimmune hepatitis; DILI: Drug-induced liver injury; HCV: Hepatitis C virus; PBC: Primary biliary cholangitis; ALD: Alcoholic liver disease.